Free Trial

Kezar Life Sciences (KZR) Earnings Date, Estimates & Call Transcripts

Kezar Life Sciences logo
$7.49 +0.11 (+1.49%)
(As of 11/20/2024 ET)

Kezar Life Sciences Latest Earnings Summary

Upcoming
Earnings Date
Mar. 13Estimated
Actual EPS
(Nov. 12)
-$2.78 Beat By $0.25
Consensus EPS
(Nov. 12)
-$3.03

Kezar Life Sciences issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$2.78, which beat analysts' consensus estimates of -$3.03 by $0.25. With a trailing EPS of -$13.18, Kezar Life Sciences' earnings are expected to decrease next year, from ($6.47) to ($8.69) per share.

KZR Upcoming Earnings

Kezar Life Sciences' next earnings date is estimated for Thursday, March 13, 2025, based off prior year's reporting schedules.

Get Kezar Life Sciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kezar Life Sciences and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

KZR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

KZR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Kezar Life Sciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.34-$0.28-$0.31
Q2 20242-$0.27-$0.26-$0.27
Q3 20242-$0.30-$0.24-$0.27
Q4 20242-$2.81-$0.17-$1.49
FY 20248-$3.72-$0.95-$2.34
Q1 20252-$2.73-$0.22-$1.48
Q2 20251-$2.75-$2.75-$2.75
Q3 20252-$2.78-$0.20-$1.49
Q4 20252-$2.80-$0.19-$1.50
FY 20257($11.06)($3.36)($7.21)

Kezar Life Sciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/13/2025
(Estimated)
------- 
11/12/2024--$3.03-$2.78+$0.25-$2.78$4.00M-
8/13/2024Q2 2024-$3.20-$2.80+$0.40-$0.26--
5/9/2024Q1 2024-$3.40-$3.00+$0.40-$0.30--
3/14/2024Q4 2023-$3.90-$3.50+$0.40-$0.26--
11/13/2023Q3 2023-$3.60-$3.20+$0.40-$0.32$0.50M$7.00M
8/10/2023Q2 2023-$3.30-$3.40 -$0.10-$0.34--
5/11/2023Q1 2023-$2.80-$3.10 -$0.30-$0.31--
3/14/2023Q4 2022-$2.40-$2.50 -$0.10-$0.25--

Kezar Life Sciences Earnings - Frequently Asked Questions

Kezar Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates. Learn more on KZR's earnings history.

In the previous quarter, Kezar Life Sciences (NASDAQ:KZR) reported ($2.78) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.03) by $0.25. Learn more on analysts' earnings estimate vs. KZR's actual earnings.

Kezar Life Sciences (NASDAQ:KZR) has a recorded annual revenue of $7 million.

Kezar Life Sciences (NASDAQ:KZR) has a recorded net income of -$101.87 million. KZR has generated -$13.18 earnings per share over the last four quarters.

Kezar Life Sciences's earnings are expected to decrease from ($6.47) per share to ($8.69) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:KZR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners